Content validity and legacy patient-reported outcome measures in cancer

This is a preview of subscription content, access via your institution.

References

  1. 1.

    US Department of Health and Human Services. Guidance for industry: Patient-reported outcome measures: use in medical product development to support labeling claims. December 2009, http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf.

  2. 2.

    DeMuro, C., Clark, M., Mordin, M., Fehnel, S., Copley-Merriman, C., & Gnanasakthy, A. (2012). Reasons for rejection of patient-reported outcome label claims: A compilation based on a review of patient-reported outcome use among new molecular entities and biologic license applications, 2006–2010. Value in Health., 15, 443–448.

    PubMed  Article  Google Scholar 

  3. 3.

    Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365–376.

    CAS  PubMed  Article  Google Scholar 

  4. 4.

    Basch, E., Abernethy, A. P., Mullins, C. D., Reeve, B. B., Smith, M. L., Coons, S. J., et al. (2012). Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology. Journal of Clinical Oncology, 30, 4249–4255.

    PubMed  Article  Google Scholar 

  5. 5.

    Velikova, G., Booth, L., Smith, A. B., Brown, P. M., Lynch, P., Brown, J. M., & Selby, P. J. (2004). Measuring quality of life in routine oncology practice improves communication and patient well-being: A randomized controlled trial. Journal of Clinical Oncology, 22, 714–724.

    PubMed  Article  Google Scholar 

  6. 6.

    DeMuro, C., Clark, M., Doward, L., Evans, E., Mordin, M., & Gnanasakthy, A. (2013). Assessment of PRO label claims granted by the FDA as compared to the EMA (2006–2010). Value in Health, 16, 1150–1155.

    PubMed  Article  Google Scholar 

  7. 7.

    EORTC Quality of Life Group. Guidelines for developing questionnaire modules 2011. Accessed October 28, 2014, http://groups.eortc.be/qol/manuals.

  8. 8.

    Reeve, B.B., Mitchell, S.A., Dueck, A.C., Basch, E., Cella, D., Reilly, C.M., Minasian, L.M., Denicoff, A.M., O’Mara, A.M., Fisch, M.J., Chauhan, C., Aaronson, N.K., Coens, C., Bruner, D.W. (2014). Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. Journal of National Cancer Institute, 106(7).

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Adam B. Smith.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Smith, A.B., Cocks, K. Content validity and legacy patient-reported outcome measures in cancer. Qual Life Res 24, 1585–1586 (2015). https://doi.org/10.1007/s11136-014-0890-6

Download citation

Keywords

  • Melanoma
  • Guidance Document
  • Comparative Effectiveness Research
  • Appetite Loss
  • Label Claim